L&g Multi-strategy Enhan... Aktie - ENCO

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

13,89

Gebot

13,80

Fragen

14,274

Volumen

3.071

13,89 Tagesbereich 14,11

0,00 52-Wochen-Bereich 0,00

Handelsende

14,086

Handelsbeginn

14,11

Letzte Trade

13.89

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial W

Company Successful with its Strategic Focus on Vaccines and Oncology Trials BERWYN, Pa., Sept. 9 /PRNewswire-FirstCall/ -- Encorium Group, Inc...

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

BERWYN, Pa., Aug. 31 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization...

Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing

WAYNE, Pa., Aug. 27 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization...

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

WAYNE, Pa., July 1 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational contract research organization...

Encorium Reports First Quarter 2009 Financial Results

Net Loss Significantly Reduced to $195,220 in First Quarter on Cost Cutting WAYNE, Pa., May 19 /PRNewswire-FirstCall/ -- Encorium Group, Inc...

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

WAYNE, Pa., May 18 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational contract research organization...

Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team

WAYNE, Pa., May 7 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full-service multinational contract research organization...

Encorium Announces Stock Buyback; Provides Business and Financial Update

WAYNE, Pa., Oct. 6 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational clinical research organization...

Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee Requirem

WAYNE, Pa., Oct. 1 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational clinical research organization...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
4OR1Organovo Holdings Inc	1,21 € (251,23%)	874,88k
2WOWide Open Agriculture Ltd	0,008 € (128,57%)	120k
E3O1Nexoptic Technology Corp	0,0195 € (62,50%)	2,05k
3IXInnergex Renewable Energy	8,918 € (52,76%)	2,22k
4PKBLAVA Therapeutics NV	1,30 € (44,44%)	33,65k
LB3CQurate Retail Inc	5,40 € (-41,30%)	186
EJ7Energy Resources of Australia	0,0015 € (-40,00%)	100k
E7TAlexium International Group Share	0,005 € (-37,50%)	11,54k
0CGChegg Inc	1,02 € (-32,66%)	183,12k
R1TBitdeer Technologies Holding Co	8,75 € (-30,08%)	32k
TKAThyssenkrupp AG	7,198 € (13,82%)	4,98M
D7GNel ASA	0,1929 € (-1,33%)	3,46M
3CPXiaomi Corporation	6,609 € (7,36%)	2,86M
DMLSayona Mining Limited	0,0135 € (-0,74%)	2,14M
R9BDeFi Technologies Inc	2,17 € (-16,38%)	1,85M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

L&g Multi-strategy Enhanced Commodities Ucits Etf (ENCO)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ENCO Neueste Nachrichten

Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial W

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

Encorium Reports First Quarter 2009 Financial Results

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team

Encorium Announces Stock Buyback; Provides Business and Financial Update

Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee Requirem

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

L&g Multi-strategy Enhanced Commodities Ucits Etf (ENCO) Börsenkurse

L&g Multi-strategy Enhanced Commodities Ucits Etf (ENCO)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ENCO Neueste Nachrichten

Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial W

Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

Encorium Reports First Quarter 2009 Financial Results

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team

Encorium Announces Stock Buyback; Provides Business and Financial Update

Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee Requirem

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP